MOG and myeloid sarcoma: In myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD), an MS-related condition defined by the presence of anti-MOG antibodies, all active demyelinating plaques were strongly positive for complement activation products [174].